Cannabinoid receptor 1 and acute resistance exercise--In vivo and in vitro studies in human skeletal muscle

Peptides
Satu PekkalaSulin Cheng

Abstract

This study aimed to determine whether Cannabinoid receptor 1 (CB1) is involved in mammalian target of rapamycin (mTOR) signaling and skeletal muscle protein synthesis. This study used human vastus lateralis skeletal muscle biopsies obtained before and after a resistance exercise (RE) bout in young men (n=18). The signaling mechanisms were studied in vitro in human myotubes. Protein expression was determined by Western blot and confocal microscopy, and gene expression by quantitative PCR. Protein synthesis was measured in vitro using puromycin-based SuNSET technique. In human skeletal muscle, an anabolic stimulus in the form of RE down-regulated CB1 expression. The negative change in CB1 expression was associated with increased phosphorylation of mTOR signaling proteins. In vitro, CB1 antagonist AM251 induced phosphorylation of mTOR downstream targets, ribosomal protein S6 kinase (S6K1), S6 and eukaryotic initiation factor 4E binding protein (4E-BP1) in human myotubes. These effects were ERK1/2-dependent and insensitive to mTOR inhibitor, rapamycin. Compared to AM251 treatment alone, inhibition of ERK1/2 by UO126 in the presence of AM251 decreased phosphorylation of S6K1, S6 and and 4E-BP1 at Thr(37/46). AM251 increased protein ...Continue Reading

References

Nov 18, 2005·The New England Journal of Medicine·Jean-Pierre DesprésUNKNOWN Rimonabant in Obesity-Lipids Study Group
Mar 16, 2006·Proceedings of the National Academy of Sciences of the United States of America·T A HornbergerS Chien
Feb 3, 2007·Molecular and Cellular Endocrinology·P CavuotoG A Wittert
Mar 28, 2008·Current Diabetes Reports·Jennifer M Perkins, Stephen N Davis
Oct 29, 2008·Proceedings of the National Academy of Sciences of the United States of America·Andrew Y ChooJohn Blenis
Jan 8, 2009·Prostaglandins & Other Lipid Mediators·Jun Wang, Natsuo Ueda
Jan 20, 2009·Journal of Applied Physiology·Micah J DrummondBlake B Rasmussen
Mar 21, 2009·Journal of Applied Physiology·Juha J HulmiAntti A Mero
Mar 24, 2009·Nature Methods·Enrico K SchmidtPhilippe Pierre
Aug 4, 2009·Nature Neuroscience·Emma PuighermanalAndrés Ozaita
Dec 15, 2010·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Craig A GoodmanTroy A Hornberger
Dec 16, 2010·Nature Reviews. Molecular Cell Biology·Roberto ZoncuDavid M Sabatini
Nov 22, 2011·European Journal of Applied Physiology·M FeuereckerA Choukèr
Feb 1, 2012·The Journal of Physiology·P J Atherton, K Smith
Feb 22, 2012·Journal of Strength and Conditioning Research·Lem W TaylorDarryn S Willoughby
Nov 13, 2012·The Journal of Urology·Anthony Atala

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Biomechanics

Biomechanics examines the generation of internal forces within the body and investigates the effects and control of forces that act on or are produced on tissues. Here are the latest discoveries.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.